Showing 1,081 - 1,100 results of 108,245 for search '(( 50 ((nn decrease) OR (we decrease)) ) OR ( 5 ((g decrease) OR (a decrease)) ))', query time: 1.65s Refine Results
  1. 1081
  2. 1082
  3. 1083
  4. 1084
  5. 1085

    Resveratrol decreases CYP17A1 and CYP21A2 protein expression. by Nesa Marti (3851059)

    Published 2017
    “…<p>A. Gene expression profiling by qRT-PCR was performed for CYP17, CYP21 and their cofactor POR in H295R cells grown under normal conditions (GM), starvation conditions (SM), metformin (Met) (1mM) treatment and under resveratrol (RSV) (5<u>μM)</u> treatment. …”
  6. 1086

    Image 2_G. vaginalis increases HSV-2 infection by decreasing vaginal barrier integrity and increasing inflammation in vivo.tif by Nuzhat Rahman (16660416)

    Published 2024
    “…The vaginal epithelium of G. vaginalis inoculated mice showed decreased DSG-1 staining compared to other groups, indicating compromised barrier function. …”
  7. 1087

    Image 3_G. vaginalis increases HSV-2 infection by decreasing vaginal barrier integrity and increasing inflammation in vivo.tif by Nuzhat Rahman (16660416)

    Published 2024
    “…The vaginal epithelium of G. vaginalis inoculated mice showed decreased DSG-1 staining compared to other groups, indicating compromised barrier function. …”
  8. 1088

    Image 1_G. vaginalis increases HSV-2 infection by decreasing vaginal barrier integrity and increasing inflammation in vivo.tif by Nuzhat Rahman (16660416)

    Published 2024
    “…The vaginal epithelium of G. vaginalis inoculated mice showed decreased DSG-1 staining compared to other groups, indicating compromised barrier function. …”
  9. 1089

    Image 4_G. vaginalis increases HSV-2 infection by decreasing vaginal barrier integrity and increasing inflammation in vivo.tif by Nuzhat Rahman (16660416)

    Published 2024
    “…The vaginal epithelium of G. vaginalis inoculated mice showed decreased DSG-1 staining compared to other groups, indicating compromised barrier function. …”
  10. 1090
  11. 1091
  12. 1092
  13. 1093

    Primary small molecule screen to identify attenuators of CSE-induced decrease in size and increase in MUC5AC. by Pranjali Beri (14945400)

    Published 2023
    “…Hit compounds at 1 and 10μM concentrations that <b>B)</b> increased spheroid size (swell) or <b>C)</b> decreased MUC5AC staining in the lumen relative to DMSO and CSE 3%-treated bronchospheres. …”
  14. 1094

    Areas of significant increases in FA (A) and decreases in MD (B) from baseline to week 10 (uncorrected <i>p</i> = 0.001, cluster size threshold = 5) used as ROIs in the gPDC analysis. by Madalina E. Tivarus (243611)

    Published 2015
    “…<p>Areas of significant increases in FA (A) and decreases in MD (B) from baseline to week 10 (uncorrected <i>p</i> = 0.001, cluster size threshold = 5) used as ROIs in the gPDC analysis.…”
  15. 1095
  16. 1096
  17. 1097
  18. 1098
  19. 1099
  20. 1100